483 related articles for article (PubMed ID: 19538319)
1. Epithelial tight junctions in intestinal inflammation.
Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
[TBL] [Abstract][Full Text] [Related]
2. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model.
Hahn S; Kim G; Jin SM; Kim JH
Biochem Biophys Res Commun; 2024 Jan; 690():149291. PubMed ID: 38006803
[TBL] [Abstract][Full Text] [Related]
4. [Role of Mitochondria in Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease].
Chernyavskij DA; Galkin II; Pavlyuchenkova AN; Fedorov AV; Chelombitko MA
Mol Biol (Mosk); 2023; 57(6):1028-1042. PubMed ID: 38062958
[TBL] [Abstract][Full Text] [Related]
5. Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD.
Gleeson JP; Estrada HQ; Yamashita M; Svendsen CN; Targan SR; Barrett RJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093254
[TBL] [Abstract][Full Text] [Related]
6. Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity.
Kröhn L; Azabdaftari A; Heuberger J; Hudert C; Zilbauer M; Breiderhoff T; Bufler P
Front Immunol; 2023; 14():1261666. PubMed ID: 37799712
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Targeting of the Inflamed Intestinal Barrier.
Farkas AE; Nusrat A
Curr Pharm Des; 2016; 22(35):5400-5414. PubMed ID: 27464718
[TBL] [Abstract][Full Text] [Related]
8. PTPN2 mutations cause epithelium-intrinsic barrier loss that synergizes with mucosal immune hyperactivation.
Sweat YY; Turner JR
J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623321
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Inflammation and Regeneration-Interdigitating Processes Controlled by Dietary Lipids in Inflammatory Bowel Disease.
Kwon SJ; Khan MS; Kim SG
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279309
[TBL] [Abstract][Full Text] [Related]
10. Excessive nucleic acid R-loops induce mitochondria-dependent epithelial cell necroptosis and drive spontaneous intestinal inflammation.
Yang X; Li G; Lou P; Zhang M; Yao K; Xiao J; Chen Y; Xu J; Tian S; Deng M; Pan Y; Li M; Wu X; Liu R; Shi X; Tian Y; Yu L; Ke H; Jiao B; Cong Y; Plikus MV; Liu X; Yu Z; Lv C
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2307395120. PubMed ID: 38157451
[TBL] [Abstract][Full Text] [Related]
11. Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells.
Hader H; Hering NA; Schulzke JD; Bücker R; Rosenthal R
Front Pharmacol; 2023; 14():1301800. PubMed ID: 38044939
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair.
Luissint AC; Parkos CA; Nusrat A
Gastroenterology; 2016 Oct; 151(4):616-32. PubMed ID: 27436072
[TBL] [Abstract][Full Text] [Related]
13. The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.
Stojancevic M; Stankov K; Mikov M
Can J Gastroenterol; 2012 Sep; 26(9):631-7. PubMed ID: 22993736
[TBL] [Abstract][Full Text] [Related]
14. The Hypoxia-Adenosine Link during Intestinal Inflammation.
Bowser JL; Phan LH; Eltzschig HK
J Immunol; 2018 Feb; 200(3):897-907. PubMed ID: 29358413
[TBL] [Abstract][Full Text] [Related]
15. Cytokine responsive networks in human colonic epithelial organoids unveil a molecular classification of inflammatory bowel disease.
Pavlidis P; Tsakmaki A; Treveil A; Li K; Cozzetto D; Yang F; Niazi U; Hayee BH; Saqi M; Friedman J; Korcsmaros T; Bewick G; Powell N
Cell Rep; 2022 Sep; 40(13):111439. PubMed ID: 36170836
[TBL] [Abstract][Full Text] [Related]
16. Adenosine in Intestinal Epithelial Barrier Function.
Stepanova M; Aherne CM
Cells; 2024 Feb; 13(5):. PubMed ID: 38474346
[TBL] [Abstract][Full Text] [Related]
17. Carrageenan as a Potential Factor of Inflammatory Bowel Diseases.
Komisarska P; Pinyosinwat A; Saleem M; Szczuko M
Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732613
[TBL] [Abstract][Full Text] [Related]
18. Induced acute hyperglycemia modifies the barrier function of the intestinal epithelium by tissue inflammation and tight junction disruption resulting in hydroelectrolytic secretion in an animal model.
Siqueira FJWS; Rodrigues FAP; Ribeiro SA; Veras HN; Ferreira FCS; Siqueira RCL; Santos AAD; Havt A; Lima AAM
Braz J Med Biol Res; 2024; 57():e13309. PubMed ID: 38656073
[TBL] [Abstract][Full Text] [Related]
19. Macromolecule Translocation across the Intestinal Mucosa of HIV-Infected Patients by Transcytosis and through Apoptotic Leaks.
Krug SM; Grünhagen C; Allers K; Bojarski C; Seybold J; Schneider T; Schulzke JD; Epple HJ
Cells; 2023 Jul; 12(14):. PubMed ID: 37508551
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathways driving disease-specific alterations of intestinal epithelial cells.
López-Posadas R; Neurath MF; Atreya I
Cell Mol Life Sci; 2017 Mar; 74(5):803-826. PubMed ID: 27624395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
